المؤلفون: Gilbert RE; Independent consultant; The TECHNA Institute; Princess Margaret Cancer Centre; Canadian Association of Provincial Cancer Agencies; University of Toronto; North York General Hospital, Toronto, Ontario; Alberta Health Services, Edmonton, Alberta; CancerCare Manitoba, Winnipeg, Manitoba; and BC Cancer Agency, Vancouver, British Columbia, Canada., Kozak MC; Independent consultant; The TECHNA Institute; Princess Margaret Cancer Centre; Canadian Association of Provincial Cancer Agencies; University of Toronto; North York General Hospital, Toronto, Ontario; Alberta Health Services, Edmonton, Alberta; CancerCare Manitoba, Winnipeg, Manitoba; and BC Cancer Agency, Vancouver, British Columbia, Canada., Dobish RB; Independent consultant; The TECHNA Institute; Princess Margaret Cancer Centre; Canadian Association of Provincial Cancer Agencies; University of Toronto; North York General Hospital, Toronto, Ontario; Alberta Health Services, Edmonton, Alberta; CancerCare Manitoba, Winnipeg, Manitoba; and BC Cancer Agency, Vancouver, British Columbia, Canada., Bourrier VC; Independent consultant; The TECHNA Institute; Princess Margaret Cancer Centre; Canadian Association of Provincial Cancer Agencies; University of Toronto; North York General Hospital, Toronto, Ontario; Alberta Health Services, Edmonton, Alberta; CancerCare Manitoba, Winnipeg, Manitoba; and BC Cancer Agency, Vancouver, British Columbia, Canada., Koke PM; Independent consultant; The TECHNA Institute; Princess Margaret Cancer Centre; Canadian Association of Provincial Cancer Agencies; University of Toronto; North York General Hospital, Toronto, Ontario; Alberta Health Services, Edmonton, Alberta; CancerCare Manitoba, Winnipeg, Manitoba; and BC Cancer Agency, Vancouver, British Columbia, Canada., Kukreti V; Independent consultant; The TECHNA Institute; Princess Margaret Cancer Centre; Canadian Association of Provincial Cancer Agencies; University of Toronto; North York General Hospital, Toronto, Ontario; Alberta Health Services, Edmonton, Alberta; CancerCare Manitoba, Winnipeg, Manitoba; and BC Cancer Agency, Vancouver, British Columbia, Canada., Logan HA; Independent consultant; The TECHNA Institute; Princess Margaret Cancer Centre; Canadian Association of Provincial Cancer Agencies; University of Toronto; North York General Hospital, Toronto, Ontario; Alberta Health Services, Edmonton, Alberta; CancerCare Manitoba, Winnipeg, Manitoba; and BC Cancer Agency, Vancouver, British Columbia, Canada., Easty AC; Independent consultant; The TECHNA Institute; Princess Margaret Cancer Centre; Canadian Association of Provincial Cancer Agencies; University of Toronto; North York General Hospital, Toronto, Ontario; Alberta Health Services, Edmonton, Alberta; CancerCare Manitoba, Winnipeg, Manitoba; and BC Cancer Agency, Vancouver, British Columbia, Canada., Trbovich PL; Independent consultant; The TECHNA Institute; Princess Margaret Cancer Centre; Canadian Association of Provincial Cancer Agencies; University of Toronto; North York General Hospital, Toronto, Ontario; Alberta Health Services, Edmonton, Alberta; CancerCare Manitoba, Winnipeg, Manitoba; and BC Cancer Agency, Vancouver, British Columbia, Canada.

المصدر: Journal of oncology practice [J Oncol Pract] 2018 May; Vol. 14 (5), pp. e295-e303. Date of Electronic Publication: 2018 Apr 20.

نوع المنشور: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101261852 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1935-469X (Electronic) Linking ISSN: 15547477 NLM ISO Abbreviation: J Oncol Pract Subsets: MEDLINE

مواضيع طبية MeSH: Drug Compounding* , Medication Errors*, Antineoplastic Agents/*adverse effects , Antineoplastic Agents/*chemistry , Neoplasms/*epidemiology, Administration, Intravenous ; Antineoplastic Agents/administration & dosage ; Canada/epidemiology ; Follow-Up Studies ; Humans ; Neoplasms/drug therapy ; Pharmacists ; Pharmacy Service, Hospital/standards ; Risk Assessment ; Risk Factors